Penn Medicine Provider
Infectious Diseases
Jessica Meisner, MD, MS, MSHP
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
Make an appointmentCall 800-789-7366

About me

  • Medical Director of HIV clinic, Prevention Point
  • Assistant Professor of Clinical Medicine (Infectious Diseases)

Education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Meisner is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Kelly PJA, Jessop AB, Scialanca M, Singley K, Luck CC, Hoadley A, Meisner J, Bass SB. Psychosocial Impact of Suspected Xylazine-Associated Skin Wounds Among People Using Fentanyl, Philadelphia, 2022 to 2023 , Subst Use Addctn J: 2024

Amanda Perez, Shane Nieves, Jessica Meisner Outcomes of LA-ART at a syringe exchange , Open Forum Infectious Diseases: 2024

Nicole Loeven, Eric Altneu, Virginie Halpern-Cohen, Kelly Dyer, Kaede Sullivan, Shara Epstein, Daniel Teixera da Silva, Jessica Meisner, Sara Schultz Increase in iGAS seen at two urban quarternary care centers in Philadelphia: Association with PWID and the unstably housed. , IDWeek2023 : 2023

Kruti J. Yagnik, Jessica A. Meisner Laboratory Testing Strategies, Detection and Diagnosis In Fundamentals of HIV Medicine 2023 Edition , AAHIVM, W David Hardy , Chapter 8: 2023,71-77

N. Loeven, K. Dyer, V. Halpern-Cohen, C. Comar, J. Meisner, L. Glaser; Macrolide and Lincosamide Susceptibility Profiles and Use of Clindamycin for iGAS in One Hosp. in Philadelphia, 2018 - 2022 , American Society of Microbiology: 2023

Zwiebel S, Meisner J, Lowenstein M National Trends in Medical and Surgical Decision-Making for Recurrent Injection Drug Use-Related Infective Endocarditis: A Survey , J Acad Consult Liaison Psychiatr, 64(1): 2023,96-98

Richard Lueking, Wenjing Wei, Norman S. Mang, Jessica K. Ortwine, Jessica Meisner Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital , Microbiology Spectrum, 11(1): 2022,e0238522.

Jain MK, De Lemos JA, McGuire DK, Ayers C, Eitson JL, Sanchez CL, Kamel D, Meisner JA, Thomas EV, Hegde AA, Mocherla S, Strebe JK, Li X, Williams NS, Xing C, Ahmed MS, Wang P, Sadek HA, Schoggins JW. Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial , Front Pharmacol, 13(1): 2022,1020123

Kruti Yagnik, Jessica Meisner Laboratory Detection Strategies: Diagnostics and Diagnosis, In: Fundamentals of HIV Medicine 2022 Edition. , AAHIVM, W David Hardy : 2022

Kalil, A. C., Mehta, A. K., Patterson, T. F., Erdmann, N., Gomez, C. A., Jain, M. K., ... & Colombo, R. E. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial , The Lancet Respiratory Medicine, 9(12): 2021,1365-1376